semaglutide and alzheimer's disease Preventative tirzepatide treatment does not alter progression in the 5xFAD mouse model of disease Semaglutide fails to slow Alzheimer's

Treadmill endurance test results corroborated these findings, demonstrating that obese mice on semaglutide regimens could run nearly as well as lean control mice

A clinical trial published in 2022 found that an older GLP-1 drug called exenatide also reduced drinking among those who had both alcohol use disorder and obesity

Weight regain often begins within weeks and accelerates in the first three months

PMID: 23129736

Cost is an important consideration, and navigating insurance coverage for these medications can often be complex and frustrating

Regular monitoring and dose titration minimize adverse events with both options